Witness Testimony

Douglas Allen, a professor of economics at Simon Fraser University, provided an expert analysis of the economic and social costs associated with COVID-19 lockdowns and related public health measures. He explained the framework of cost-benefit analysis as applied to pandemic policy, emphasizing the need to compare projected health benefits with measurable economic and societal harms. His testimony focused on evaluating whether non-pharmaceutical interventions, including lockdowns, achieved their intended reductions in mortality.
Allen reviewed comparative mortality data and international outcomes, stating that jurisdictions with stricter lockdown measures did not consistently demonstrate better health results than those with less restrictive approaches. He discussed excess mortality metrics, statistical modeling limitations, and the challenges of isolating policy effects from other variables. He further addressed broader consequences such as GDP losses, reduced employment, mental health impacts, and disruptions to education and healthcare services.
He concluded that pandemic policy decisions should be subject to rigorous empirical evaluation and transparent economic analysis. According to his assessment, the aggregate costs of lockdown policies were substantial, and the evidence of proportional health benefits was limited, raising questions about the overall effectiveness and justification of such interventions.